Meitav Investment House’s Chemomab Therapeutics CMMB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-8,756
| Closed | -$129K | – | 362 |
|
|
2022
Q2 | $129K | Hold |
8,756
| – | – | ﹤0.01% | 327 |
|
|
2022
Q1 | $167K | Sell |
8,756
-636
| -7% | -$12.1K | ﹤0.01% | 375 |
|
|
2021
Q4 | $259K | Hold |
9,392
| – | – | ﹤0.01% | 357 |
|
|
2021
Q3 | $416K | Sell |
9,392
-774
| -8% | -$34.3K | 0.01% | 327 |
|
|
2021
Q2 | $773K | Buy |
10,166
+8,088
| +389% | +$615K | 0.02% | 266 |
|
|
2021
Q1 | $239 | Buy |
+2,078
| New | +$239 | 0.01% | 342 |
|
|
2020
Q4 | – | Sell |
-3,663
| Closed | -$267K | – | 418 |
|
|
2020
Q3 | $267K | Sell |
3,663
-2,035
| -36% | -$148K | 0.01% | 347 |
|
|
2020
Q2 | $500K | Buy |
+5,698
| New | +$500K | 0.03% | 223 |
|
|
2020
Q1 | – | Sell |
-5,813
| Closed | -$521K | – | 390 |
|
|
2019
Q4 | $521K | Sell |
5,813
-478
| -8% | -$42.8K | 0.04% | 230 |
|
|
2019
Q3 | $972K | Buy |
6,291
+238
| +4% | +$36.8K | 0.07% | 170 |
|
|
2019
Q2 | $1.74M | Buy |
6,053
+5,645
| +1,384% | +$1.62M | 0.12% | 101 |
|
|
2019
Q1 | $177K | Buy |
+408
| New | +$177K | 0.01% | 364 |
|